Research: Needle/syringe programs highly cost-effective for hep C prevention in UK

According to research published in Addiction, needle and syringe programs are a highly cost-effective means of preventing hepatitis C transmission among people who inject drugs. Investment in such programming, the results show, could save millions of pounds in treatment costs in the United Kingdom (UK). Using data from three UK cities, the researchers estimated the…

Research: Modelling for microelimination in 3 regions of Switzerland

New research published in Swiss Medical Weekly models the current epidemiology of hepatitis C virus in three regions of Switzerland, identifying increases in diagnosis and treatment rates that may be required to achieve the goals of the Swiss Hepatitis Strategy. According to the study, elimination of chronic hepatitis C infection in eastern (region of St…

News: Europe’s hepatitis challenge

An article published in the Bulletin of the World Health Organization (WHO) this month looks at the factors slowing progress in preventing and treating hepatitis B and C infections in Europe. Experts consulted highlight vaccination, voluntary testing, policy development, a focus on high-risk groups like intravenous drug users, standardized data collection, and service integration as…